PITX2
Pituitary homeobox 2
Also known as: ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, PITX2_HUMAN, RGS, RIEG, RIEG1, RS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99697
- Gene
- PITX2
- Ensembl
- ENSG00000164093
- Chromosome
- 4
- Canonical length
- 317 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the RIEG/PITX homeobox family, which is in the bicoid class of homeodomain proteins. The encoded protein acts as a transcription factor and regulates procollagen lysyl hydroxylase gene expression. This protein plays a role in the terminal differentiation of somatotroph and lactotroph cell phenotypes, is involved in the development of the eye, tooth and abdominal organs, and acts as a transcriptional regulator involved in basal and hormone-regulated activity of prolactin. Mutations in this gene are associated with Axenfeld-Rieger syndrome, iridogoniodysgenesis syndrome, and sporadic cases of Peters anomaly. A similar protein in other vertebrates is involved in the determination of left-right asymmetry during development. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>Q99697|PITX2
1 METNCRKLVS ACVQLGVQPA AVECLFSKDS EIKKVEFTDS PESRKEAASS KFFPRQHPGA
61 NEKDKSQQGK NEDVGAEDPS KKKRQRRQRT HFTSQQLQEL EATFQRNRYP DMSTREEIAV
121 WTNLTEARVR VWFKNRRAKW RKRERNQQAE LCKNGFGPQF NGLMQPYDDM YPGYSYNNWA
181 AKGLTSASLS TKSFPFFNSM NVNPLSSQSM FSPPNSISSM SMSSSMVPSA VTGVPGSSLN
241 SLNNLNNLSS PSLNSAVPTP ACPYAPPTPP YVYRDTCNSS LASLRLKAKQ HSSFGYASVQ
301 NPASNLSACQ YAVDRPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PITX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 40 nTPM
- placenta: 40 nTPM
- urinary bladder: 27 nTPM
- tongue: 26 nTPM
- pituitary gland: 13 nTPM
- salivary gland: 11 nTPM
Single-cell type
- thymic myoid cells: 94 nCPM
- gonadotrophs: 90 nCPM
- thyrotrophs: 66 nCPM
- myosatellite cells: 54 nCPM
- fibroblasts: 53 nCPM
- pituitary stem cells: 52 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 30 nTPM
- thalamus: 10 nTPM
- midbrain: 4.7 nTPM
- pons: 0.5 nTPM
- spinal cord: 0.4 nTPM
- basal ganglia: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PITX2.
Disease | AllUniProt
Conditions PITX2 is implicated in, by any mechanism.
- Axenfeld-Rieger syndrome 1 (RIEG1) MIM:180500
- Anterior segment dysgenesis 4 (ASGD4) MIM:137600
- Ring dermoid of cornea (RDC) MIM:180550
Disease | GeneticClinVar
80 pathogenic / likely-pathogenic of 257 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Axenfeld-Rieger syndrome type 1
- Anterior segment dysgenesis 4
- Inborn genetic diseases
- Anterior segment dysgenesis
- PITX2-related disorder
ReferencesPubMed · IEDB
Publications for PITX2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.55
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- atrial cardiac muscle tissue morphogenesis
- atrioventricular valve development
- branching involved in blood vessel morphogenesis
- camera-type eye development
- cardiac neural crest cell migration involved in outflow tract morphogenesis
- cell proliferation involved in outflow tract morphogenesis
- deltoid tuberosity development
- determination of left/right symmetry
- embryonic camera-type eye development
- embryonic digestive tract morphogenesis
- embryonic heart tube left/right pattern formation
- embryonic hindlimb morphogenesis
- endodermal digestive tract morphogenesis
- extraocular skeletal muscle development
- hair cell differentiation
- hypothalamus cell migration
- in utero embryonic development
- iris morphogenesis
- left lung morphogenesis
- left/right axis specification
- negative regulation of transcription by RNA polymerase II
- neuron migration
- odontogenesis
- outflow tract morphogenesis
- positive regulation of cell population proliferation
- positive regulation of transcription by RNA polymerase II
- prolactin secreting cell differentiation
- pulmonary myocardium development
- pulmonary vein morphogenesis
- regulation of cell migration
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- somatotropin secreting cell differentiation
- spleen development
- vascular associated smooth muscle cell differentiation
- vasculogenesis
- ventricular cardiac muscle cell development
- ventricular septum morphogenesis
- Wnt signaling pathway
- subthalamic nucleus development
- superior vena cava morphogenesis
Molecular functions
- chromatin DNA binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- identical protein binding
- phosphoprotein binding
- protein homodimerization activity
- ribonucleoprotein complex binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PITX2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PITX2 as an antibody target. Whether an autoantibody or antibody against PITX2 could matter depends on whether native PITX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PITX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PITX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...